OBJECTIVE: To examine the association between obesity and serum and ultrasound measures of ovarian reserve in late reproductive age women. DESIGN: Cross-sectional study of 36 healthy women, ages 40 to 52 years. Women were recruited in a 1:1 ratio of normal weight (body mass index <25) to obese women (body mass index >or=30). Early follicular phase blood draw, anthropometric measurements, and a transvaginal ultrasonography were performed. Outcome measures were serum antimullerian hormone, inhibin B, estradiol, follicle-stimulating hormone, ultrasound ovarian volume, and antral follicle count. RESULTS: Mean antral follicle count was 7.6 for normal weight and 6.3 for obese women (P = 0.35). Proportions of normal weight (17%) versus obese women (22%) with antral follicle count less than 4 were similar. Ovarian volumes did not differ by body size. In adjusted models, antimullerian hormone levels in obese women were 77% lower on average than those in normal weight women (P = 0.02). Inhibin B levels were 24% lower in obese women compared with normal weight women (P = 0.08). Follicle-stimulating hormone and estradiol were not associated with body mass index. CONCLUSIONS: Although antral follicle count did not differ by body size, antimullerian hormone was lower in obese compared with normal weight late reproductive age women. These data suggest that lower antimullerian hormone levels in obese late reproductive age women result from physiologic processes other than decreased ovarian reserve.
OBJECTIVE: To examine the association between obesity and serum and ultrasound measures of ovarian reserve in late reproductive age women. DESIGN: Cross-sectional study of 36 healthy women, ages 40 to 52 years. Women were recruited in a 1:1 ratio of normal weight (body mass index <25) to obesewomen (body mass index >or=30). Early follicular phase blood draw, anthropometric measurements, and a transvaginal ultrasonography were performed. Outcome measures were serum antimullerian hormone, inhibin B, estradiol, follicle-stimulating hormone, ultrasound ovarian volume, and antral follicle count. RESULTS: Mean antral follicle count was 7.6 for normal weight and 6.3 for obesewomen (P = 0.35). Proportions of normal weight (17%) versus obesewomen (22%) with antral follicle count less than 4 were similar. Ovarian volumes did not differ by body size. In adjusted models, antimullerian hormone levels in obesewomen were 77% lower on average than those in normal weight women (P = 0.02). Inhibin B levels were 24% lower in obesewomen compared with normal weight women (P = 0.08). Follicle-stimulating hormone and estradiol were not associated with body mass index. CONCLUSIONS: Although antral follicle count did not differ by body size, antimullerian hormone was lower in obese compared with normal weight late reproductive age women. These data suggest that lower antimullerian hormone levels in obese late reproductive age women result from physiologic processes other than decreased ovarian reserve.
Authors: John F Randolph; MaryFran Sowers; Ellen B Gold; Beth A Mohr; Judith Luborsky; Nanette Santoro; Daniel S McConnell; Joel S Finkelstein; Stanley G Korenman; Karen A Matthews; Barbara Sternfeld; Bill L Lasley Journal: J Clin Endocrinol Metab Date: 2003-04 Impact factor: 5.958
Authors: Janet W Rich-Edwards; Donna Spiegelman; Miriam Garland; Ellen Hertzmark; David J Hunter; Graham A Colditz; Walter C Willett; Handan Wand; JoAnn E Manson Journal: Epidemiology Date: 2002-03 Impact factor: 4.822
Authors: H G Burger; E C Dudley; J L Hopper; N Groome; J R Guthrie; A Green; L Dennerstein Journal: J Clin Endocrinol Metab Date: 1999-11 Impact factor: 5.958
Authors: John E Hall; Daniel W Jones; Jay J Kuo; Alexandre da Silva; Lakshmi S Tallam; Jiankang Liu Journal: Curr Hypertens Rep Date: 2003-10 Impact factor: 5.369
Authors: Nanette Santoro; Bill Lasley; Dan McConnell; Jenifer Allsworth; Sybil Crawford; Ellen B Gold; Joel S Finkelstein; Gail A Greendale; Jenny Kelsey; Stan Korenman; Judith L Luborsky; Karen Matthews; Rees Midgley; Lynda Powell; Janice Sabatine; Miriam Schocken; Mary Fran Sowers; Gerson Weiss Journal: J Clin Endocrinol Metab Date: 2004-06 Impact factor: 5.958
Authors: Siobán D Harlow; Margery Gass; Janet E Hall; Roger Lobo; Pauline Maki; Robert W Rebar; Sherry Sherman; Patrick M Sluss; Tobie J de Villiers Journal: J Clin Endocrinol Metab Date: 2012-02-16 Impact factor: 5.958
Authors: N D Shaw; S S Srouji; C K Welt; K H Cox; J H Fox; J M Adams; P M Sluss; J E Hall Journal: J Clin Endocrinol Metab Date: 2013-11-27 Impact factor: 5.958
Authors: Lia A Bernardi; Mercedes R Carnethon; Peter J de Chavez; Deborah E Ikhena; Lisa M Neff; Donna D Baird; Erica E Marsh Journal: Obesity (Silver Spring) Date: 2016-12-07 Impact factor: 5.002
Authors: G Lambert-Messerlian; M B Roberts; S S Urlacher; J Ah-Ching; S Viali; M Urbanek; S T McGarvey Journal: Hum Reprod Date: 2011-06-15 Impact factor: 6.918
Authors: Melissa F Wellons; Gordon Wright Bates; Pamela J Schreiner; David S Siscovick; Barbara Sternfeld; Cora E Lewis Journal: Menopause Date: 2013-08 Impact factor: 2.953
Authors: Kimberly A Bertrand; Heather J Baer; E John Orav; Catherine Klifa; Ajay Kumar; Nola M Hylton; Erin S LeBlanc; Linda G Snetselaar; Linda Van Horn; Joanne F Dorgan Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-05-09 Impact factor: 4.254
Authors: Lauren W Roth; Amanda A Allshouse; Erica L Bradshaw-Pierce; Jennifer Lesh; Justin Chosich; Wendy Kohrt; Andrew P Bradford; Alex J Polotsky; Nanette Santoro Journal: Clin Endocrinol (Oxf) Date: 2014-03-20 Impact factor: 3.478